NewsWatch: Dow sets new intraday record as Moderna vaccine progress bolsters market’s least-loved shares

This post was originally published on this site

MARKETWATCH FRONT PAGE

Stocks rise sharply Monday, in a rally fueled by optimism over progress toward a COVID-19 vaccine. See full story.

Moderna’s COVID-19 vaccine candidate sparks market rally after achieving 94.5% efficacy in late-stage trial and requires only standard refrigeration

Moderna Inc. said Monday its COVID-19 vaccine candidate met its primary endpoint in a Phase 3 trial, demonstrating 94.5% efficacy, a far higher benchmark than originally expected, sparking a broad-based market rally. See full story.

Joe Biden didn’t get a ‘blue wave’ but here are 5 ways he can advance his tax agenda

With two Senate seats up for grabs, what does this mean for families thinking about their tax bill in a Biden era? See full story.

Trump acknowledges Biden presidential election win for first time — then says he ‘concedes nothing,’ repeating unfounded claim of ‘rigged’ vote

Donald Trump on Sunday tweeted his first tacit acknowledgment of former Vice President Joe Biden’s election victory, but continued to claim the democratic election was “rigged” and fraudulent without providing any evidence and after other agencies have deemed the voting process one of the most secure in U.S. history. See full story.

Is it safe to have Thanksgiving with family? Here are the latest CDC guidelines on holiday gatherings

If you visit others, bring your own food, dishes and utensils, the agency suggests. See full story.

MARKETWATCH PERSONAL FINANCE

‘Cytokine storms,’ a hyperinflammatory immune response to the influenza of 1918, were seen as one reason healthy people were so hard hit. How big a role have they played in 2020? See full story.